|
|
|
Insider
Information: |
Makhzoumi Mohamad |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
16,083 |
|
Indirect Shares
|
68,130,184 |
|
|
Direct
Value |
$200,625 |
|
|
Indirect Value
|
$216,417,739 |
|
|
Total
Shares |
68,146,267 |
|
|
Total
Value |
$216,618,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
2
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
2
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
23.7%
|
-32.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
2022-10-19 |
559 |
2022-10-19 |
354 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
11,348 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2019-12-09 |
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-05-25 |
0 |
2021-05-24 |
0 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
2021-06-08 |
1,273 |
2021-06-08 |
806 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Bright Health Group Inc. |
BHG |
|
2024-05-12 |
5,943 |
2024-05-12 |
2,280,552 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
Robinhood Markets, Inc. |
HOOD |
Director |
2022-05-02 |
6,371 |
2022-05-03 |
0 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
1,654 |
2022-11-16 |
1,047 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
283 |
2022-12-21 |
0 |
Premium* |
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2019-05-09 |
4 |
B |
$10.00 |
$25,000,000 |
I/I |
2,500,000 |
4,438,562 |
1.5 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,938,562 |
1,938,562 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2020-04-03 |
4 |
S |
$2.66 |
$1,500 |
I/I |
(564) |
5,937,998 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2020-04-03 |
4 |
OE |
$0.00 |
$1,500 |
I/I |
1,500,000 |
5,938,562 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2021-10-18 |
4 |
B |
$0.00 |
$0 |
I/I |
1,851,852 |
7,789,850 |
1.42 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2022-04-11 |
4 |
B |
$1.90 |
$6,802,999 |
I/I |
3,580,526 |
948,948 |
1.5 |
- |
|
SVRA |
Savara Inc |
10% Owner |
|
2021-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,137,931 |
|
% |
|
SVRA |
Savara Inc |
10% Owner |
|
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2017-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,989,010 |
|
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2019-05-07 |
4 |
B |
$1.08 |
$1,227,640 |
I/I |
1,136,704 |
2,052,454 |
1.5 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2020-12-04 |
4 |
B |
$0.62 |
$2,735,930 |
I/I |
4,398,602 |
6,451,056 |
1.5 |
% |
|
NKTX |
Nkarta, Inc. |
10% Owner |
|
2020-07-14 |
4 |
B |
$18.00 |
$11,999,988 |
I/I |
666,666 |
2,902,115 |
1.5 |
- |
|
NKTX |
Nkarta, Inc. |
10% Owner |
|
2020-07-14 |
4 |
A |
$0.00 |
$0 |
I/I |
2,235,449 |
2,235,449 |
0 |
- |
|
MTCR |
Metacrine, Inc. |
10% Owner |
|
2020-09-18 |
4 |
B |
$13.00 |
$9,999,990 |
I/I |
769,230 |
3,060,527 |
1.5 |
- |
|
MTCR |
Metacrine, Inc. |
10% Owner |
|
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,291,297 |
2,291,297 |
0 |
- |
|
MTCR |
Metacrine, Inc. |
10% Owner |
|
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
0 |
- |
|
MTCR |
Metacrine, Inc. |
10% Owner |
|
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
0 |
- |
|
MRKR |
Marker Therapeutics Inc |
10% Owner |
|
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2019-07-22 |
4 |
B |
$15.00 |
$6,750,000 |
I/I |
450,000 |
4,186,243 |
1.5 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
3,736,243 |
3,736,243 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
41,501 |
11,348 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
KRRO |
Korro Bio |
10% Owner |
|
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,072,936 |
|
- |
|
KRRO |
Korro Bio |
|
|
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(11,867,242) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|